Clinical Virology Unit, Department of Clinical Microbiology and Infectious Diseases.
Intensive Care Unit, Hadassah Hebrew University Medical Center.
Clin Infect Dis. 2019 Aug 30;69(6):1049-1052. doi: 10.1093/cid/ciz053.
Patients admitted to hospital with influenza B and A in Jerusalem, Israel, during the 2015-2016 and 2017-2018 influenza seasons demonstrated similar rates of intensive care unit (ICU) admission and associated disease severity. Most (63%) influenza B ICU patients received influenza B-mismatched trivalent vaccine. These findings call into question the equivalence of trivalent and quadrivalent vaccines in preventing severe influenza B.
在 2015-2016 年和 2017-2018 年流感季节，在以色列耶路撒冷因流感 B 和 A 住院的患者表现出类似的重症监护病房（ICU）入院率和相关疾病严重程度。大多数（63%）流感 B ICU 患者接受了流感 B 错配的三价疫苗。这些发现质疑了三价和四价疫苗在预防严重流感 B 方面的等效性。
